Loading market data...

Emcure Pharmaceuticals IPO

Pharmaceuticals - Listed on 10 July 2024

+31.5% listing gain
Issue Price (Upper)
Rs 1,008
Listing Price
Rs 1,325.05
Closing Price (NSE)
Rs 1,359.15
Total Subscription
67.84x

Emcure Pharmaceuticals IPO listing summary

Emcure Pharmaceuticals (Pharmaceuticals) closed its IPO window in 2024 and listed on NSE and BSE on 10 July 2024 at an upper band issue price of Rs 1008, opening at Rs 1325.05 for a listing gain of +31.5% and closing day one at Rs 1359.15 (+34.8% on closing basis). The IPO was subscribed 67.84x overall - QIB 195.83x, HNI/NII 48.28x, Retail 7.17x. The total issue size was Rs 1,952.03 Cr (Fresh Issue Rs 1152.03 Cr, OFS Rs 800 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+31.45%
Listing Gain (Close)
+34.84%
Day Change After Listing
+3.38%
Retail Quota
10.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB195.83x
HNI / NII48.28x
Retail7.17x
Overall67.84x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 11.32x
Day 24.98x
Day 3 (Final)67.84x

Emcure Pharmaceuticals IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 260+35.71%
Day 2Rs 275+36.21%
Day 3Rs 282+35.22%
Day 4Rs 310+31.75%
Day 5Rs 320+30.75%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
30.8%-36.2%
IPOGyani AI Prediction
-
Actual Listing Gain
+31.5%

Issue & financials

Issue SizeRs 1,952.03 Cr
Fresh IssueRs 1,152.03 Cr
OFSRs 800 Cr
IPO PE38.26
Peer / Sector PE40.41
PE vs Sector Ratio0.95
Latest EBITDA (Cr)19.01
Debt / Equity0.67

Market context at listing

How the broader market moved around the Emcure Pharmaceuticals IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return+0.33%
Nifty 1W Return+1.70%
Nifty 1M Return+7.27%
Nifty during IPO window+0.74%

Emcure Pharmaceuticals IPO - FAQs

What was the listing gain of Emcure Pharmaceuticals IPO?

Emcure Pharmaceuticals IPO listed at +31.5% versus the upper issue price of Rs 1,008 on 10 July 2024.

How many times was Emcure Pharmaceuticals IPO subscribed?

Emcure Pharmaceuticals IPO was subscribed 67.84x overall. QIB portion was subscribed 195.83x, HNI / NII 48.28x and Retail 7.17x.

What was the IPO GMP for Emcure Pharmaceuticals?

IPO GMP started at Rs 260 on Day 1 and moved to Rs 320 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2024

Browse listed IPOs by year